SFDA approves China Medical Technologies' colorectal cancer assay

[News]

China Medical Technologies, Inc., a leading China-based advanced in-vitro diagnostic company, today announced that China's State Food and Drug Administration has approved the Company's real-time PCR-based V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog assay as a companion diagnostic test for the use of a targeted drug for the treatment of colorectal cancer patients.

More... (http://www.news-medical.net/news/20111013/SFDA-approves-China-Medical-Technologies-colorectal-cancer-assay.aspx)